PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT

BACKGROUND AND OBJECTIVES: The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated that intensive BP lowering reduced the risk of cardiovascular disease, but increased eGFR decline. Serum parathyroid hormone (PTH) and fibroblast growth factor-23 (FGF23) concentrations are elevated in CK...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin J Am Soc Nephrol
Main Authors: Ginsberg, Charles, Craven, Timothy E., Chonchol, Michel B., Cheung, Alfred K., Sarnak, Mark J., Ambrosius, Walter T., Killeen, Anthony A., Raphael, Kalani L., Bhatt, Udayan Y., Chen, Jing, Chertow, Glenn M., Freedman, Barry I., Oparil, Suzanne, Papademetriou, Vasilios, Wall, Barry M., Wright, Clinton B., Ix, Joachim H., Shlipak, Michael G.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6302330/
https://ncbi.nlm.nih.gov/pubmed/30425104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.05390518
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados